18.08.2016 • NewsElaine BurridgeBayerMonsanto

Bayer Gets Limited Access to Monsanto’s Books

“In the coming weeks, CEO Werner Baumann will make a decision; namely whether...
“In the coming weeks, CEO Werner Baumann will make a decision; namely whether a friendly merger is still possible, or whether Bayer must choose an alternative path,” sources told Handelsblatt.

Monsanto is reported to have given Bayer limited access to its books after last month rejecting an improved takeover offer of $125/share, or around $65 billion. The parties have not yet signed a non-disclosure agreement, which would allow Bayer to conduct due diligence, but Monsanto is giving the German company a “limited drip” of information, according to Reuters news agency.

Sources said Bayer had no appetite to put a deal at risk by going hostile, although talks were “difficult.” An earlier news report in German business publication Handelsblatt, citing sources close to management, stated that Bayer officials were preparing to “turn directly to shareholders” to secure a deal if Monsanto insisted on a price which the Germans perceived as too risky. The US agrochemicals giant called the latest bid in July “financially inadequate.

 “In the coming weeks, CEO Werner Baumann will make a decision; namely whether a friendly merger is still possible, or whether Bayer must choose an alternative path,” sources told Handelsblatt.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.